Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04513925 |
|---|---|
| Brief Title: | A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (SKYSCRAPER-03) |
| First Submitted : | August 13, 2020 |
| First Submitted that Met QC Criteria : | August 13, 2020 |
| First Posted : | August 14, 2020 |
| Last Update Submitted that Met QC Criteria : | February 27, 2024 |
| Last Update Posted : | February 28, 2024 |